#United States #Canton #Kelyniam #Ross Bjella #Corporate Updates

Kelyniam Global Inc. Corporate Updates for 2025

On January 21, 2025, Ross Bjella, the CEO of Kelyniam Global Inc., made an important announcement regarding the company's progress and future plans. As part of its routine pre-March disclosures, Kelyniam is poised to report impressive results for the fiscal year 2024, with revenue exceeding $3.3 million. This marks a significant growth rate of at least 25% compared to the previous year.

Financial Highlights

Kelyniam is also set to declare an increase in operating income, projected to reach approximately $500,000 for 2024, signifying a robust performance in its core operations. The details surrounding these results will be disclosed in mid-March, providing stakeholders with crucial insights into the company's performance.

In addition, Kelyniam has undertaken a thorough evaluation of legacy costs and obligations stemming from the COVID-19 pandemic. The outcome of this analysis will be reflected in the company's annual financial statements, focusing on both non-cash matters and restructuring costs related to obsolete inventory and asset disposition.

Anticipated Changes

Kelyniam is preparing to adapt to upcoming changes in its trading requirements as announced by its Broker-Dealer marketplace, OTCIQ. Plans are in place for Kelyniam to qualify for a move to the OTCID Basic Market in 2025, aiming to enhance liquidity and accessibility for its shareholders.

To facilitate this, the company is considering a reverse stock split that could be executed following the annual shareholders meeting scheduled for late June 2025. This strategic move aims to improve the current trading price, which is below $1, thus allowing greater opportunities for investors.

Investor Engagement

On January 29 at 2:00 PM ET, an investor presentation organized by GeoInvesting will provide further details about the company's strategy and performance projections. The presentation will adopt a fireside chat format, allowing for an engaging and informative discussion. Interested investors can register for the event through GeoInvesting’s platform.

Closing Remarks

Kelyniam's CEO expressed optimism about the company's future, stating, "Kelyniam left 2024 with strong momentum, and we are excited about the prospects for 2025." The company continues to focus on revolutionizing the healthcare sector by producing custom cranial and maxillo-facial implants through advanced manufacturing technologies.

Kelyniam Global Inc. remains dedicated to enhancing clinical outcomes by collaborating with surgeons and health systems, ensuring both quality and affordability for patients in need.

For more information about Kelyniam and its products, visit their official website: Kelyniam.com.

Forward-Looking Statements

It’s important to note that the contents of this announcement may include forward-looking statements. Such statements carry inherent risks and uncertainties that could lead actual results to differ from anticipated outcomes, which may stem from various factors including economic conditions, competitive dynamics, and operational execution.